Skip to main content
SpringerLink
Log in

Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

BTG2 (B cell translocation gene 2) is downregulated in several human tumors and has been known as a tumor suppressor in carcinogenesis of thymus, prostate, kidney, and liver. However, little is known about the role BTG2 plays in gastric adenocarcinoma. In the present study, we intended to investigate the influence of BTG2 on the growth, proliferation, apoptosis, invasion and cell cycle of the gastric cancer cell lines SGC7901 and MKN45. BTG2 cDNA was insected into a constitutive vector pcDNA3.1 followed by transfection in gastric cancer cell line MKN45 and SGC7901 by using liposome. Then stable transfectants were selected and appraised. The apoptosis and cell cycles of these transfectants were analyzed by using flow cytometric assay. The growth and proliferation were analyzed by cell growth curves and colony-forming assay, respectively. The invasion of these clones was analyzed by using cell migration assay. MKN-BTG2 (MKN45 with stable transfection of BTG2 gene) and SGC-BTG2 (SGC7901 with stable transfection of BTG2 gene) grew slower than their control groups, respectively. The cell counts of MKN-BTG2 in the fourth, fifth, sixth and seventh days were significantly fewer than those of control groups (P < 0.05). Those of SGC-BTG2 in the fourth fifth, sixth and seventh days were significantly fewer than those of control groups too (P < 0.05). Cell cycle analysis showed that proportions of MKN-BTG2 and SGC-BTG2 cells in G0–G1 and S were different significantly with those of their control groups, respectively (P < 0.05). The apoptosis rate of MKN-BTG2 was significantly higher than those of control groups (P < 0.05). Results of colony-forming assay showed that the colon formation rates of MKN-BTG2 and SGC-BTG2 were lower than those of their control groups (P < 0.05). The results of cell migration assay showed that the cell migration rates of MKN-BTG2 and SGC-BTG2 were not significantly different with those of their control groups (P > 0.05). BTG2 can restrain the growth and proliferation of gastric cancer cells powerfully. It can reduce some malignant phenotype of these tumor cells. But it could not impact the ability of invasion of gastric cancer cells, so could not restrain the metastasis of gastric cancer. In gastric cancer, BTG2 could be thought as a tumor-inhibiting gene in some distance, so the gene could be a potential target of gene therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108. doi:10.3322/canjclin.55.2.74

    Article  PubMed  Google Scholar 

  2. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354–362

    PubMed  Google Scholar 

  3. Stein HJ, Sendler A, Fink U, Siewert JR (2000) Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 80:659–682. doi:10.1016/S0039-6109(05)70205-X

    Article  CAS  PubMed  Google Scholar 

  4. Ikematsu N et al (1999) Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18:7432–7441. doi:10.1038/sj.onc.1203193

    Article  CAS  PubMed  Google Scholar 

  5. Buanne P et al (2000) Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics 68:253–263. doi:10.1006/geno.2000.6288

    Article  CAS  PubMed  Google Scholar 

  6. Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the Tis21/PC3/BTG1/TOB family. FEBS Lett 497:67–72. doi:10.1016/S0014-5793(01)02436-X

    Article  CAS  PubMed  Google Scholar 

  7. Guchenneux F et al (1997) Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11:370–375. doi:10.1038/sj.leu.2400599

    Article  Google Scholar 

  8. Felice T (2001) The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187:155–165. doi:10.1002/jcp.1062

    Article  Google Scholar 

  9. Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, Tsaimorris CH (1987) A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1:343–355

    CAS  PubMed  Google Scholar 

  10. Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR (1991) Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511–14518

    CAS  PubMed  Google Scholar 

  11. Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A (2002) The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 282:207–214. doi:10.1016/S0378-1119(01)00825-3

    Article  CAS  PubMed  Google Scholar 

  12. Lim IK, Lee MS, Lee SH, Kim NK, Jou I, Seo JS, Park SC (1995) Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 121:279–2848. doi:10.1007/BF01209594

    Article  CAS  PubMed  Google Scholar 

  13. Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H (2004) Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 64:1632–1638. doi:10.1158/0008-5472.CAN-03-1687

    Article  CAS  PubMed  Google Scholar 

  14. Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271–1279. doi:10.1093/carcin/22.8.1271

    Article  CAS  PubMed  Google Scholar 

  15. Wang Y, Shao C, Shi CH, Zhang L, Yue HH, Wang PF, Yang B, Zhang YT, Liu F, Qin WJ, Wang H, Shao GX (2005) Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Asian J Androl 7:375–380. doi:10.1111/j.1745-7262.2005.00031.x

    Article  CAS  PubMed  Google Scholar 

  16. Shaobo Y, Mengwei W, Yong S, Weidi Y, Weihua W (2004) Screening differentially expressed genes of gastric adenocarcinoma by cDNA microarray. China J Cancer Prev Treat 11:117–120

    Google Scholar 

  17. Shao Y, Yang SB, Wang MW, Wu BY, You WD, Li H (2004) Gene expression profile of human adenocarcinoma by cDNA microarray and clustering. Chin J Med Genet 21:110–115

    CAS  Google Scholar 

  18. Farioli-Vecchioli S, Tanori M, Micheli L, Mancuso M, Leonardi L, Saran A, Ciotti MT, Ferretti E, Gulino A, Pazzaglia S, Tirone F (2007) Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J 21:2215–2225. doi:10.1096/fj.06-7548com

    Article  CAS  PubMed  Google Scholar 

  19. Lim IK (2006) TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol 132:417–426. doi:10.1007/s00432-006-0080-1

    Article  CAS  PubMed  Google Scholar 

  20. Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S (2006) Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66:7075–7082. doi:10.1158/0008-5472.CAN-06-0379

    Article  CAS  PubMed  Google Scholar 

  21. Donato LJ, Suh JH, Noy N (2007) Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res 67:609–615. doi:10.1158/0008-5472.CAN-06-0989

    Article  CAS  PubMed  Google Scholar 

  22. Evangelisti C, Astolfi A, Gaboardi GC, Tazzari P, Pession A, Goto K, Martelli AM (2009) TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. Cell Signal 21:801–809. doi:10.1016/j.cellsig.2009.01.027

    Article  CAS  PubMed  Google Scholar 

  23. Guardavaccaro D, Corrente G, Covone F, Micheli L, D’Agnano I, Starace G, Caruso M, Tirone F (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797–1815. doi:10.1128/MCB.20.5.1797-1815.2000

    Article  CAS  PubMed  Google Scholar 

  24. Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK (2004) TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res 299:159–170. doi:10.1016/j.yexcr.2004.05.014

    Article  CAS  PubMed  Google Scholar 

  25. el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A (2002) BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21:6772–6778. doi:10.1038/sj.onc.1205888

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Drs Haili Huang and Gangshi Wang, and Nurse Weidi You, Shiping Xu et al., for handling patient contacts. We wish to thank the Forth Military Medical University of PLA for providing means for the current investigation. This work was supported by grants from the National Natural Science Foundation of China (30600728).

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Second Affiliated Hospital of General Hospital of PLA, 100091, Beijing, China

    Lin Zhang & Kai Wu

  2. Department of Geriatric Gastroenterology, General Hospital of PLA, 100853, Beijing, China

    Haili Huang, Mengwei Wang & Benyan Wu

Authors
  1. Lin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haili Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mengwei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Benyan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lin Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Huang, H., Wu, K. et al. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep 37, 2579–2586 (2010). https://doi.org/10.1007/s11033-009-9777-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9777-y

Keywords

Search

Navigation